Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. S. Shostak"'
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 84-89 (2024)
A patient with a subacute course of systemic sclerosis (SSc) and a three-phase Raynaud's phenomenon at the onset of the disease is described. The diagnosis was made in accordance with the ACR/EULAR 2013 criteria. Within 8 months of disease onset, the
Externí odkaz:
https://doaj.org/article/d51a90dfdca14df8bdac73edb7fe989c
Publikováno v:
Современная ревматология, Vol 17, Iss 2, Pp 72-76 (2023)
The article presents the results of treatment of patients with systemic lupus erythematosus (SLE), who, due to resistance to traditional regimens, for the first time in the Russian Federation were included in the early access program of the type I in
Externí odkaz:
https://doaj.org/article/a10a790e0ca0496bb090fdb810702bdf
Autor:
Ya. A. Leineman, A. Yu. Bessalova, D. B. Aliev, R. R. Samigullina, M. S. Shostak, I. Z. Gaidukova, V. I. Mazurov
Publikováno v:
Современная ревматология, Vol 16, Iss 4, Pp 69-73 (2022)
The article describes a clinical case of systemic lupus erythematosus (SLE) resistant to traditional treatment regimens and the first successful experience with the type I interferon inhibitor – anifrolumab, as part of an early access program in th
Externí odkaz:
https://doaj.org/article/ee66431a08fc40698941968942785399
Autor:
V. I. Mazurov, A. M. Lila, O. V. Shadrivova, M. S. Tonkoshkur, M. S. Shostak, L. V. Martynova, O. V. Inamova, M. S. Petrova, A. Yu. Fonturenko, E. A. Desyatik, Yu. V. Borzova, Yu. E. Melekhina, I. S. Bogomolova, S. M. Ignatyeva, N. N. Klimko
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 16-22 (2020)
Objective: to study risk factors for invasive aspergillosis (IA), its etiology, clinical manifestations, and treatment efficiency in patients with rheumatic diseases (RD).Patients and methods. The first study of proven and probable IA (EORT/MSGERC, 2
Externí odkaz:
https://doaj.org/article/8947bc4a33c5439588ea624f9c1663dd
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 4, Pp 519-524 (2018)
When rheumatoid arthritis (RA) is treated with rituximab (RTM), there may be various adverse events, among which progressive multifocal leukoencephalopathy (PML) occupies a special place. The disease is caused by activation of opportunistic viral (JC
Externí odkaz:
https://doaj.org/article/a91b60d9a0bb4339870cffb553302d78
Autor:
Yu. E. Melekhina, M. S. Tonkoshkur, M. S. Shostak, V. I. Mazurov, I. S. Bogomolova, M. S. Petrova, A. M. Lila, E. A. Desyatik, Nikolay Klimko, L. V. Martynova, Yu. V. Borzova, S. M. Ignatyeva, O. V. Shadrivova, A. Yu. Fonturenko, O. V. Inamova
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 16-22 (2020)
Objective: to study risk factors for invasive aspergillosis (IA), its etiology, clinical manifestations, and treatment efficiency in patients with rheumatic diseases (RD).Patients and methods. The first study of proven and probable IA (EORT/MSGERC, 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52dcfd84f1ea10ce42889d97fce09b4b
https://doi.org/10.14412/1996-7012-2020-4-16-22
https://doi.org/10.14412/1996-7012-2020-4-16-22